Top Page
|
English
|
简体中文
|
繁體中文
|
한국어
|
日本語
Home
|
About us
|
Services
|
Partners
|
Events
|
Contact us
|
Login
Friday, May 3, 2024
Press Releases for Friday, May 29, 2020
AbbVie and Eisai Announce an Approval for Partial Changes in the Marketing Approval of HUMIRA, a Fully Human Anti-TNFalpha Monoclonal Antibody
14:54 HKT/SGT
Sharp Releases Notice of Corporate Spin-Off of the Display Device Business Division
14:47 HKT/SGT
DENSO Announces Changes in the Areas of Responsibility of Senior Executive Officers and Executive Officers
11:05 HKT/SGT
Eisai: Results from LENVIMA (lenvatinib) plus KEYTRUDA (pembrolizumab) Trials
10:31 HKT/SGT
Paice, Abell, and Daimler Agree to License Patented Technology
06:00 HKT/SGT
ACN Search:
RSS
News Alerts
Copyright © 2024 ACN Newswire - Asia Corporate News Network
Home
|
About us
|
Services
|
Partners
|
Events
|
Login
|
Contact us
|
Privacy Policy
|
Terms of Use
|
RSS
US: +1 214 890 4418 | Beijing: +86 400 879 3881 | Hong Kong: +852 8192 4922 | Singapore: +65 6549 7068 | Tokyo: +81 3 6859 8575
Connect With us:
